Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1963;28(2):139–173.

Tests for addiction (chronic intoxication) of morphine type

H Halbach, Nathan B Eddy
PMCID: PMC2554465  PMID: 13952049

Abstract

A survey is presented of laboratory and clinical methods for the determination of addiction liability of substances with morphine-like effects. Since physical dependence is the outstanding pharmacological criterion of addiction of morphine type, the procedures for its qualitative and quantitative assessment are described in detail.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUMOELLER F. L., TERRY J. G. Nalline: an aid in detecting narcotic users. Calif Med. 1956 Nov;85(5):299–301. [PMC free article] [PubMed] [Google Scholar]
  2. CASS L. J., LAING J. T., FREDERIK W. S. Physical dependence potentiality of analgesics. Curr Ther Res Clin Exp. 1961 Jul;3:289–299. [PubMed] [Google Scholar]
  3. COCHIN J., DALY J. W. Rapid identification of analgesic drugs in urine with thin-layer chromatography. Experientia. 1962 Jun 15;18:294–295. doi: 10.1007/BF02148245. [DOI] [PubMed] [Google Scholar]
  4. CULLUMBINE H., KONOP T. S. The relation between drug-induced excitation in the cat and addiction liability. Can J Biochem Physiol. 1959 Sep;37:1075–1079. [PubMed] [Google Scholar]
  5. DESMAREZ J. J. [Contribution to the experimental study of tranquilizing substances and toxicomanogenic drugs]. Ann Soc R Sci Med Nat Brux. 1960;13:125–contd. [PubMed] [Google Scholar]
  6. EDDY N. B., HALBACH H., BRAENDEN O. J. Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances. Bull World Health Organ. 1956;14(3):353–402. [PMC free article] [PubMed] [Google Scholar]
  7. EDDY N. B., LEE L. E., Jr, HARRIS C. [Physical dependence and tolerance in relation to various analgesics in patients suffering from chronic pains; comparison between morphine, oxymorphone and anileridine]. Bull World Health Organ. 1959;20:1245–1256. [PMC free article] [PubMed] [Google Scholar]
  8. EDDY N. B., LEE L. E., Jr The analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone). J Pharmacol Exp Ther. 1959 Feb;125(2):116–121. [PubMed] [Google Scholar]
  9. FRASER H. F., MARTIN W. R., WOLBACH A. B., ISBELL H. Addiction liability of an isoquinoline analgesic, 1-(p-chlorophenethyl)-2-methyl-6,7-dimethoxy-1.2.3.4-tetrahydroisoquinoline. Clin Pharmacol Ther. 1961 May-Jun;2:287–299. doi: 10.1002/cpt196123287. [DOI] [PubMed] [Google Scholar]
  10. FRASER H. F., VAN HORN G. D., MARTIN W. R., WOLBACH A. B., ISBELL H. Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test. J Pharmacol Exp Ther. 1961 Sep;133:371–387. [PubMed] [Google Scholar]
  11. HANNA C. A demonstration of morphine tolerance and physical dependence in the rat. Arch Int Pharmacodyn Ther. 1960 Mar 1;124:326–329. [PubMed] [Google Scholar]
  12. JACOB J., BLOZOVSKI M., ECHINARDGARIN P. Propriétés analgésiques de quatre amino-méthyl-2-benzolyl-benzodioxans. Therapie. 1958;13(1):17–29. [PubMed] [Google Scholar]
  13. KAYMAKCALAN S., WOODS L. A. Nalorphine-induced abstinence syndrome in morphine-tolerant albino rats. J Pharmacol Exp Ther. 1956 May;117(1):112–116. [PubMed] [Google Scholar]
  14. KUHN H. F., FRIEBEL H. [On the demonstration of "physical dependence" in codeine-treated rats]. Med Exp Int J Exp Med. 1962;6:301–306. [PubMed] [Google Scholar]
  15. MARTIN W. R., EADES C. G. Demonstration of tolerance and physical dependence in the dog following a short-term infusion of morphine. J Pharmacol Exp Ther. 1961 Aug;133:262–270. [PubMed] [Google Scholar]
  16. MASON C. C., SHEPHERD H. G. Evaluation of two screening procedures for detecting the use of opiates. Am J Clin Pathol. 1962 Feb;37:176–181. doi: 10.1093/ajcp/37.2.176. [DOI] [PubMed] [Google Scholar]
  17. MERCIER J., ETZENSPERGER P., CHATAIN R. A. Peut-on utiliser la souris pour déterminer l'accoutumance par la méthode de la tolérance aux doses toxiques? Ann Pharm Fr. 1957 Dec;15(12):701–712. [PubMed] [Google Scholar]
  18. MERCIER J., SESTIER M. R. Déterminations de l'accoutumance à la morphine et de l'influence du sevrage en toxique par une méthode psycho-physiologique. Ann Pharm Fr. 1954 Jun;12(6):458–465. [PubMed] [Google Scholar]
  19. PATON W. D. The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol Chemother. 1957 Mar;12(1):119–127. doi: 10.1111/j.1476-5381.1957.tb01373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PHATAK N. M., DAVID N. A. Addiction potentialities of some methadone analgesics and alpha acetylmethadol as determined by their hyperglycemic responses in rabbits. Curr Res Anesth Analg. 1953 Jul-Aug;32(4):242–249. [PubMed] [Google Scholar]
  21. SCHRAPPE O., BURCHARD J. M., GEHLKEN K. Semiquantitative Bestimmung der körperlichen Gewöhnung (physical dependence) bei Morphin- und Methadon-Therapie. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1959;199(1):19–35. doi: 10.1007/BF00361098. [DOI] [PubMed] [Google Scholar]
  22. SEEVERS M. H. Termination of drug action by tolerance development. Fed Proc. 1958 Dec;17(4):1175–1181. [PubMed] [Google Scholar]
  23. WHAT to do with a drug addict. J Am Med Assoc. 1952 Jul 26;149(13):1220–1223. [PubMed] [Google Scholar]
  24. WIKLER A., CARTER R. L. Effects of single doses of N-Allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction. J Pharmacol Exp Ther. 1953 Sep;109(1):92–101. [PubMed] [Google Scholar]
  25. WIKLER A., FRANK K. Hindlimb reflexes of chronic spinal dots during cycles of addiction to morphine and methadon. J Pharmacol Exp Ther. 1948 Dec;94(4):382–400. [PubMed] [Google Scholar]
  26. WIKLER A., FRASER H. F., ISBELL H. N-Allylnormorphine: effects of single doses and precipitation of acute abstinence syndromes during addiction to morphine; methadone or heroin in man (post addicts). J Pharmacol Exp Ther. 1953 Sep;109(1):8–20. [PubMed] [Google Scholar]
  27. WINTER C. A., FLATAKER L. Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs. J Pharmacol Exp Ther. 1950 Mar;98(3):305–317. [PubMed] [Google Scholar]
  28. WINTER C. A., ORAHOVATS P. D., FLATAKER L., LEHMAN E. G., LEHMAN J. T. Studies on the pharmacology of N-allylnormorphine. J Pharmacol Exp Ther. 1954 Jun;111(2):152–160. [PubMed] [Google Scholar]
  29. WOODS L. A., DENEAU G. A., BENNETT D. R., DOMINO E. F., SEEVERS M. H. A comparison of the pharmacology of two potent analgesic agents, piminodine (Win 14,098-2) and Win 13,797, with morphine and meperidine. Toxicol Appl Pharmacol. 1961 May;3:358–379. doi: 10.1016/0041-008x(61)90072-2. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES